Introduction: Myoblast transfer therapy in the new millennium

Cell Transplantation

Volumn 9, Issue 4, 2000, Pages 485-487

  Grounds, M D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA GALACTOSIDASE; CORTICOSTEROID; DEFLAZACORT; METALLOPROTEINASE; PREDNISOLONE; PROTEINASE; TRYPSIN;

CELL CULTURE; CELL DEATH; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFER; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; MUSCLE INNERVATION; MUSCLE NECROSIS; MYOBLAST; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CELL MOTION; CELL TRANSPLANTATION; CYTOLOGY; MUSCLE; PHYSIOLOGY; TRANSPLANTATION;

ADRENAL CORTEX HORMONES; ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; HUMANS; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 0034231158     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900405     Document Type: Conference Paper

References (27)

1. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse
2. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy
3. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source
4. Quantitative studies of the efficacy of myoblast transplantation
5. The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury
6. Rapid death of injected myoblasts in myoblast transfer therapy
7. Muscle regeneration by bone marrow-derived myogenic progenitors
8. A factor implicated in the myogenic conversion of nonmuscle cells derived from the mouse dermis
9. Editorial: Satellite cells and myoblast transfer therapy
10. Muscle regeneration: Molecular aspects and therapeutic implications
11. Dystrophin expression in the mdx mouse restored by stem cell transplantation
12. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse I: Clenbuterol
13. + cells
14. Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection
15. Myoblast transplantation in the mouse: What cells do we use?
16. Hematopoietic potential of stem cells isolated from murine skeletal muscle
17. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: Correlation with repair
18. Thymic myoid cells as a source of cells for myoblast transfer
19. The 'fantastic voyage' of muscle progenitor cells
20. The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscle
21. Enhanced donor myoblast migration and fusion in normal and dystrophic host muscle
22. Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: Implications for myoblast transfer therapy
23. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases
24. Myoblast transplantation: A brief review of the problems and some solutions
25. Migration of muscle cells